EUVIMEDOpdag EUVIMED
VergleichsstudieKohortenstudie

Comparative risk of ventricular arrhythmia and sudden cardiac death among acetylcholinesterase inhibitors in dementia: A population‐based cohort study

Hsi-Yu Lai, Lin-Chieh Meng, Yi-Jia Ye, Ho-Min Chen, Liang-Kung Chen, Fei-Yuan Hsiao iD

British Journal of Clinical Pharmacology · 2026

DOI: 10.1002/bcp.70656 ↗

At a glance

Vergleichsstudie in British Journal of Clinical Pharmacology, 2026. Written by Hsi-Yu Lai and 5 co-authors. Institution: Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan. Major MEDLINE topics: Cholinesterase Inhibitors, Death, Sudden, Cardiac, Dementia, Arrhythmias, Cardiac. 27 references. Funded by: Taiwan Ministry of Science and Technology, Taiwan National Science and Technology Council, Interdisciplinary Research Center for Healthy Longevity of National Yang Ming Chiao Tung University.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Previous studies have suggested that acetylcholinesterase inhibitors (AChEIs) may be associated with an increased risk of ventricular arrhythmia or sudden cardiac death, potentially related to QTc prolongation. However, evidence comparing the real‐world risk of severe cardiac conduction outcomes among the three AChEIs—donepezil, galantamine and rivastigmine—remains limited.

Objective

This study aimed to compare the risk of ventricular arrhythmia or sudden cardiac death associated with the use of different AChEIs in older adults with dementia.

Methods

We conducted a retrospective cohort study using Taiwan's National Health Insurance database. Older adults diagnosed with dementia who initiated AChEI therapy between 2010 and 2019 were identified and categorized according to the AChEI prescribed. Participants were followed until the end of 2020. Stabilized inverse probability of treatment weighting was applied to balance baseline characteristics, with rivastigmine serving as the reference group. Cox proportional hazards models were used to estimate hazard ratios for ventricular arrhythmia or sudden cardiac death.

Results

A total of 66 589 older adults with dementia initiating AChEI therapy were included. Donepezil was the most frequently prescribed AChEI (64.8%), followed by rivastigmine (33.0%) and galantamine (2.3%). Compared with rivastigmine, IPTW‐weighted analyses showed no significant association between donepezil use (HR 0.95, 95% CI, 0.82–1.09) or galantamine use (HR 1.40, 95% CI, 0.90–2.18) and the risk of ventricular arrhythmia or sudden cardiac death.

Conclusions

The risk of ventricular arrhythmia or sudden cardiac death was comparable among donepezil, galantamine and rivastigmine in older patients with dementia.

Subjects

MeSH terms (MEDLINE)

Cholinesterase InhibitorsDeath, Sudden, CardiacDementiaArrhythmias, CardiacHumansAgedRetrospective StudiesFemaleMaleRivastigmineTaiwanGalantamineDonepezilAged, 80 and overRisk Factors

Author keywords

Alzheimer's diseaseacetylcholinesterase inhibitordementiasudden cardiac deathventricular arrhythmia

Substances

Cholinesterase InhibitorsRivastigmineGalantamineDonepezil

Authors and institutions

  • Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Health Data Research Center, National Taiwan University, Taipei, Taiwan.
  • Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Center for Geriatrics and Gerontology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Taipei Municipal Gan-Dau Hospital (Managed by Taipei Veterans General Hospital), Taipei, Taiwan.

ORCID profiles: Fei-Yuan Hsiao

Funding

  • Taiwan Ministry of Science and Technology
  • Taiwan National Science and Technology Council
  • Interdisciplinary Research Center for Healthy Longevity of National Yang Ming Chiao Tung University
  • Ministry of Science and Technology, Taiwan

Cite

APA

Lai, H. Y., Meng, L. C., Ye, Y. J., Chen, H. M., Chen, L. K., & Hsiao, F. Y. (2026). Comparative risk of ventricular arrhythmia and sudden cardiac death among acetylcholinesterase inhibitors in dementia: A population‐based cohort study. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70656

Vancouver

Lai HY, Meng LC, Ye YJ, Chen HM, Chen LK, Hsiao FY. Comparative risk of ventricular arrhythmia and sudden cardiac death among acetylcholinesterase inhibitors in dementia: A population‐based cohort study. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70656

BibTeX
@article{Lai2026,
  author = {Lai, Hsi-Yu and Meng, Lin-Chieh and Ye, Yi-Jia and Chen, Ho-Min and Chen, Liang-Kung and Hsiao, Fei-Yuan},
  title = {Comparative risk of ventricular arrhythmia and sudden cardiac death among acetylcholinesterase inhibitors in dementia: A population‐based cohort study},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70656}
}
Start for free →